• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Vaccitech Plc ADR (NQ: VACC )

    N/A UNCHANGED
    Last Price Updated: 4:00 PM EST, Nov 6, 2023 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Vaccitech Plc ADR

    < Previous 1 2 3 4 Next >
    Vaccitech Renames as Barinthus Biotherapeutics to Highlight Strategic Evolution into a T Cell Immunotherapy Company Targeting Chronic Infectious Diseases, Autoimmunity, and Cancer
    From Barinthus Biotherapeutics
    Via GlobeNewswire
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
    It's time to start off the week with a breakdown of the biggest pre-market stock movers that investors need to know about for Monday! 
    Via InvestorPlace
    Analyst Expectations for Vaccitech's Future
    Via Benzinga
    Vaccitech: Q1 Earnings Insights
    Via Benzinga
    Vaccitech Earnings Perspective: Return On Capital Employed
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Intraday Session
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For September 25, 2023
    Via Benzinga
    Investigational Immunotherapy Treatments Offering Promise in Treating Pancreatic Cancer as Risk Factors Rise
    EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:VACC),(NASDAQ:BPTS),(NASDAQ:RNAZ),(NYSE:BMY) EQNX::TICKER_END 
    Via FinancialNewsMedia
    Vaccitech to Host KOL Webinar on Seeking a Functional Cure for Chronic Hepatitis B on September 20, 2023
    From Vaccitech plc
    Via GlobeNewswire
    Stocks That Hit 52-Week Lows On Monday
      Monday's session saw 175 companies set new 52-week lows. 
    Via Benzinga
    Vaccitech Reports Second Quarter 2023 Financial Results and Recent Corporate Developments
    From Vaccitech plc
    Via GlobeNewswire
    Stocks That Hit 52-Week Lows On Thursday
      On Thursday, 283 companies set new 52-week lows. 
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Via Benzinga
    Vaccitech to Present Positive Final Data at EASL Congress for Phase 1b/2 HBV002 Study in Adults with Chronic Hepatitis B
    From Vaccitech plc
    Via GlobeNewswire
    Arbutus Doses First Patient in Additional Treatment Arm of Phase 2a Triple Combination Clinical Trial that Includes a PD-1 Monoclonal Antibody
    From Arbutus Biopharma Corporation
    Via GlobeNewswire
    Vaccitech Doses First Patient in PCA001, a Prostate Cancer Phase 1/2 Clinical Trial of VTP-850 Immunotherapeutic Candidate in Men with Rising PSA after Definitive Local Therapy
    From Vaccitech plc
    Via GlobeNewswire
    Over $4M Bet On Diversified Healthcare Trust? Check Out These 4 Stocks Under $5 Insiders Are Aggressively Buying
    The Dow Jones closed higher by around 150 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... 
    Via Benzinga
    Vaccitech Presents Interim Data from Phase 1b/2 Study of VTP-200 at 35th Annual International Papillomavirus Conference (IPVC) Highlighting Favorable Tolerability and Immunogenicity Profile
    From Vaccitech plc
    Via GlobeNewswire
    7 Thrilling Biotech Stocks for Aggressive Investors to Buy
    Amid the noise of the global markets recently, these speculative biotech stocks to buy might trade with a mind of their own. 
    Via InvestorPlace
    Vaccitech Announces Positive Topline Final Data for HBV002 Study in People with Chronic Hepatitis B
    From Vaccitech plc
    Via GlobeNewswire
    12 Health Care Stocks Moving In Friday's Intraday Session
    Via Benzinga
    Why Scholastic Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Friday's Mid-Day Session
    Gainers Near Intelligence Inc. (NASDAQ: NIR) shares climbed 53.1% to $16.50. 
    Via Benzinga
    Crude Oil Down 1%; US Composite PMI Jumps In March
    U.S. stocks traded lower midway through trading, with the Dow Jones dropping around 80 points on Friday. The Dow traded down 0.26% to 32,021.81 while the NASDAQ fell 0.41% to 11,739.58. The S&P 500,... 
    Via Benzinga
    Vaccitech Reports Full-Year 2022 Financial Results and an Update on Corporate Developments
    From Vaccitech plc
    Via GlobeNewswire
    Vaccitech’s VTP-200 Ph 1b/2 Study Demonstrates Favorable Tolerability and Immunogenicity Profile at Interim Analysis in Women with Low-Grade Human Papillomavirus (HPV)-related Cervical Lesions
    From Vaccitech plc
    Via GlobeNewswire
    Why Block Shares Are Trading Lower By Over 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Gainers DiamondHead Holdings Corp. (NASDAQ: DHHC) shares jumped 104.2% to $21.15. DiamondHead entered into convertible note purchase agreement dated March 21, 2023. 
    Via Benzinga
    Vaccitech Appoints Industry Veteran, Nadège Pelletier, Ph.D., as Chief Scientific Officer
    From Vaccitech plc
    Via GlobeNewswire
    < Previous 1 2 3 4 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.